Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Iodohippurate Sodium I 131
2. Hippuran-131
3. Hippuran I 131
4. Iodohippurate Sodium I-131
5. 881-17-4
6. Iodohippurate I131 Sodium
7. Iodohippurate Sodium I131
8. Sodium Iodohippurate (131 I)
9. Iodohippurate Sodium,i-131
10. Sodium Iodohippurate I 131
11. Monosodium O-iodo-(sup 131)i-hippurate
12. Iodohippurate Sodium, I-131
13. 9brv734r3e
14. Sodium Iodohippurate (131i) [inn]
15. Sodium;2-[(2-(131i)iodanylbenzoyl)amino]acetate
16. Hipputope
17. Unii-9brv734r3e
18. Natrii Iodohippuras Iodo-131
19. Natrii Iodhippuras (131 I)
20. Iodohipurato Sodico (131 I)
21. Natrii Jod (131 I)-hippuras
22. Natrium Jod (131 J)-hippuricum
23. Iodohippurate (131 I) De Sodium
24. Hippuran I131
25. Natrium Radioiodhippuricum (131 I)
26. Iodohippurate Sodium I 131 [usan]
27. Iodohippurate Sodium I 131 [usan:usp]
28. Natrii Iodhippuras (131 I) [inn-latin]
29. Iodohipurato Sodico (131 I) [inn-spanish]
30. Hippuran I 131 (tn)
31. Iodohippurate (131 I) De Sodium [inn-french]
32. Sodium Iodohippurate 131i)
33. Chembl1200763
34. Iodohippurate Sodium ((131)i)
35. Dtxsid90236816
36. Chebi:134740
37. Sodium 2-((131)i)iodohippurate
38. Iodohippurate Sodium I 131 (usp)
39. Sodium Iodohippurate 131i) Injection
40. Db09382
41. Sodium Iodohippurate (131i) Injection
42. Sodium [2-((131)i)iodobenzamido]acetate
43. Sodium Iodohippurate (131i) (jp17/inn)
44. Iodohippurate Sodium,i-131 [vandf]
45. D04570
46. O-iodohippurate Sodium 131i-labeled Form
47. Sodium Iodohippurate (131 I) [who-dd]
48. Iodohippurate Sodium I 131 [usp Impurity]
49. Iodohippurate Sodium I-131 [orange Book]
50. O-iodohippurate Sodium 131i-labeled Form [mi]
51. Q27272329
52. Glycine, N-(2-(iodo-(sup 131)i)benzoyl)-, Monosodium Salt
| Molecular Weight | 331.05 g/mol |
|---|---|
| Molecular Formula | C9H7INNaO3 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 3 |
| Exact Mass | 330.938489 g/mol |
| Monoisotopic Mass | 330.938489 g/mol |
| Topological Polar Surface Area | 69.2 Ų |
| Heavy Atom Count | 15 |
| Formal Charge | 0 |
| Complexity | 237 |
| Isotope Atom Count | 1 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
V - Various
V09 - Diagnostic radiopharmaceuticals
V09C - Renal system
V09CX - Other renal system diagnostic radiopharmaceuticals
V09CX02 - Sodium iodohippurate (131I)
ABOUT THIS PAGE
79
PharmaCompass offers a list of Iodohippurate Sodium I-131 API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Iodohippurate Sodium I-131 manufacturer or Iodohippurate Sodium I-131 supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Iodohippurate Sodium I-131 manufacturer or Iodohippurate Sodium I-131 supplier.
PharmaCompass also assists you with knowing the Iodohippurate Sodium I-131 API Price utilized in the formulation of products. Iodohippurate Sodium I-131 API Price is not always fixed or binding as the Iodohippurate Sodium I-131 Price is obtained through a variety of data sources. The Iodohippurate Sodium I-131 Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Iodohippurate sodium I 131 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Iodohippurate sodium I 131, including repackagers and relabelers. The FDA regulates Iodohippurate sodium I 131 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Iodohippurate sodium I 131 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Iodohippurate sodium I 131 supplier is an individual or a company that provides Iodohippurate sodium I 131 active pharmaceutical ingredient (API) or Iodohippurate sodium I 131 finished formulations upon request. The Iodohippurate sodium I 131 suppliers may include Iodohippurate sodium I 131 API manufacturers, exporters, distributors and traders.
Iodohippurate sodium I 131 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Iodohippurate sodium I 131 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Iodohippurate sodium I 131 GMP manufacturer or Iodohippurate sodium I 131 GMP API supplier for your needs.
A Iodohippurate sodium I 131 CoA (Certificate of Analysis) is a formal document that attests to Iodohippurate sodium I 131's compliance with Iodohippurate sodium I 131 specifications and serves as a tool for batch-level quality control.
Iodohippurate sodium I 131 CoA mostly includes findings from lab analyses of a specific batch. For each Iodohippurate sodium I 131 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Iodohippurate sodium I 131 may be tested according to a variety of international standards, such as European Pharmacopoeia (Iodohippurate sodium I 131 EP), Iodohippurate sodium I 131 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Iodohippurate sodium I 131 USP).
